http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100650162-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-706 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6837 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-68 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2003-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2006-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100650162-B1 |
| titleOfInvention | Microarray for detecting drug-resistant hepatitis virus containing a quality control probe and a negative control probe and a method for detecting drug-resistant hepatitis virus using the same |
| abstract | The present invention relates to target probes for detecting drug-resistant hepatitis B virus (HBV) and QC probes for quality control of the microarray fabrication and hybridization process, and one or more wild type Microarrays made by mixing negative control probes for determination of the degree and extent of mutation type mixing, background measurements by nonspecific cross hybridization reactions, or for distinguishing homozygotes from heterozygotes. The present invention relates to a method for detecting drug-resistant HBV virus, quality control of microarrays, determination of the degree and mixture of one or more types, and determination of positive and false positives for each probe.n n n The microarray according to the present invention includes a drug-resistant hepatitis B virus detection target probe, a QC probe, and a negative control probe to detect drug-resistant hepatitis B virus, to manufacture a microarray, and to control the quality of the hybridization reaction process. In addition to determining the degree and extent of mixing of more than one wild type and mutation type, positive and false positive determinations for each probe by background measurements by nonspecific cross hybridization reactions, or homozygote and heterozygote distinction, They are attached to one set and attached to a plurality of sets on one support. In one single experiment, multiple drug-resistant hepatitis B viruses can be detected simultaneously from multiple samples, quality control and the mixing of wild type and mutation, and the degree of mixing and each probe. Fast and accurate determination of positive and false positives This makes diagnostics and measurement are possible. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009085575-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013168851-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009085575-A2 |
| priorityDate | 2003-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 187.